E.V.A BIOSYSTEMS LIMITED
Executive Summary
E.V.A Biosystems Limited is a small, early-stage biotech company showing signs of financial recovery with positive net assets in its latest accounts. While regulatory compliance is sound and management is stable, the company’s reliance on advanced subscriptions and historical negative equity warrants careful scrutiny. Further due diligence on funding structure and operational viability is recommended to assess ongoing risk.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 22/08/2522 August 2025 New | Sub-division of shares on 2025-04-15 |
| 20/08/2520 August 2025 New | Confirmation statement made on 2025-08-08 with no updates |
| 19/08/2519 August 2025 New | Resolutions |
| 03/02/253 February 2025 | Total exemption full accounts made up to 2024-08-31 |
| 31/08/2431 August 2024 | Annual accounts for year ending 31 Aug 2024 |
| 12/08/2412 August 2024 | Confirmation statement made on 2024-08-08 with no updates |
| 04/03/244 March 2024 | Total exemption full accounts made up to 2023-08-31 |
| 31/08/2331 August 2023 | Annual accounts for year ending 31 Aug 2023 |
| 08/08/238 August 2023 | Confirmation statement made on 2023-08-08 with no updates |
| 09/02/239 February 2023 | Total exemption full accounts made up to 2022-08-31 |
| 31/08/2231 August 2022 | Annual accounts for year ending 31 Aug 2022 |
| 09/08/219 August 2021 | Incorporation |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company